Figure 4.

BBM inhibits the migration and invasion of triple negative breast cancer cells. Cells were treated with BBM (10, 20 and 40 µM), migration and invasion were tested using (A) wound closure assays (scale bar, 100 µm) and (B) quantified. (C) Transwell and Matrigel transwell assay cell images (scale bar, 100 µm) and (D) quantification of the results. The Ctrl group was untreated cells. Data are presented as the mean ± standard deviation (n=3). *P<0.05, **P<0.01, ***P<0.001 vs. Ctrl group. BBM, Berbamine; Ctrl, control.